
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $210 | -- | -- | -- | -- | |
Gross Profit | -$210 | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $203.2K | $176.1K | $174.2K | $158.4K | $179.9K | |
Other Inc / (Exp) | $14.6K | $890 | -$4.7K | -$190 | -$1.5K | |
Operating Expenses | $203.2K | $176.1K | $174.2K | $158.4K | $179.9K | |
Operating Income | -$203.4K | -$176.1K | -$174.2K | -$158.4K | -$179.9K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$187.1K | -$168.2K | -$193.2K | -$191.8K | -$244.4K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$187.1K | -$168.2K | -$193.2K | -$191.8K | -$244.4K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$187.1K | -$168.2K | -$193.2K | -$191.8K | -$244.4K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -- | -- | -- | |
Weighted Average Basic Share | $598.1M | $861.1M | $861.1M | $861.1M | $861.1M | |
Weighted Average Diluted Share | $598.1M | $861.1M | $861.1M | $861.1M | $861.1M | |
EBITDA | -$186.9K | -$168.2K | -$182.5K | -$159.2K | -$182.2K | |
EBIT | -$187.1K | -$168.2K | -$182.5K | -$159.2K | -$182.2K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$203.4K | -$176.1K | -$174.2K | -$158.4K | -$179.9K | |
Operating Income (Adjusted) | -$187.1K | -$168.2K | -$182.5K | -$159.2K | -$182.2K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $90 | -- | -- | -- | -- | |
Gross Profit | -$90 | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $64.3K | $49.9K | $42.8K | $46.6K | $68.2K | |
Other Inc / (Exp) | $17.2K | $3K | -$920 | -$20 | -$250 | |
Operating Expenses | $64.3K | $49.9K | $42.8K | $46.6K | $68.2K | |
Operating Income | -$64.4K | -$49.9K | -$42.8K | -$46.6K | -$68.2K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$44.9K | -$46.6K | -$50.2K | -$58.8K | -$85.8K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$44.9K | -$46.6K | -$50.2K | -$58.8K | -$85.8K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$44.9K | -$46.6K | -$50.2K | -$58.8K | -$85.8K | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | $0.00 | $0.00 | $0.00 | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | $0.00 | $0.00 | $0.00 | |
Weighted Average Basic Share | $863M | $861.1M | $861.1M | $861.1M | $861.1M | |
Weighted Average Diluted Share | $863M | $861.1M | $861.1M | $861.1M | $861.1M | |
EBITDA | -$48K | -$46.6K | -$45.1K | -$47.1K | -$68.8K | |
EBIT | -$48.1K | -$46.6K | -$45.1K | -$47.1K | -$68.8K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$64.4K | -$49.9K | -$42.8K | -$46.6K | -$68.2K | |
Operating Income (Adjusted) | -$48.1K | -$46.6K | -$45.1K | -$47.1K | -$68.8K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $200 | -- | -- | -- | -- | |
Gross Profit | -$200 | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $203.2K | $176.1K | $173.8K | $158.3K | $179.9K | |
Other Inc / (Exp) | $14.6K | $900 | -$4.7K | -$200 | $7.1M | |
Operating Expenses | $203.2K | $176.1K | $173.8K | $158.3K | $179.9K | |
Operating Income | -$203.4K | -$176.1K | -$173.8K | -$158.3K | -$179.9K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$187.1K | -$168.2K | -$192.8K | -$191.8K | $6.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$187.1K | -$168.2K | -$193.2K | -$191.8K | -$244.4K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$187.1K | -$168.2K | -$193.2K | -$191.8K | $6.9M | |
Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -- | -- | $0.01 | |
Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -- | -- | $0.01 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$186.8K | -$168.2K | -$182.2K | -$159.2K | $7M | |
EBIT | -$187.1K | -$168.2K | -$182.2K | -$159.2K | $7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$203.4K | -$176.1K | -$173.8K | -$158.3K | -$179.9K | |
Operating Income (Adjusted) | -$187.1K | -$168.2K | -$182.2K | -$159.2K | $7M |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $176.1K | $173.8K | $158.4K | $179.9K | -- | |
Other Inc / (Exp) | $890 | -$4.7K | -$200 | $7.1M | -- | |
Operating Expenses | $176.1K | $173.8K | $158.4K | $179.9K | -- | |
Operating Income | -$176.1K | -$173.8K | -$158.4K | -$179.9K | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$168.2K | -$192.8K | -$191.8K | $6.9M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$168.2K | -$193.2K | -$191.8K | -$244.4K | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$168.2K | -$193.2K | -$191.8K | $6.9M | -- | |
Basic EPS (Cont. Ops) | -$0.00 | $0.00 | -$0.00 | $0.01 | -- | |
Diluted EPS (Cont. Ops) | -$0.00 | $0.00 | -$0.00 | $0.01 | -- | |
Weighted Average Basic Share | $3.4B | $3.4B | $3.4B | $3.4B | -- | |
Weighted Average Diluted Share | $3.4B | $3.4B | $3.4B | $3.4B | -- | |
EBITDA | -$168.2K | -$182.2K | -$159.2K | $7M | -- | |
EBIT | -$168.2K | -$182.2K | -$159.2K | $7M | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$176.1K | -$173.8K | -$158.4K | -$179.9K | -- | |
Operating Income (Adjusted) | -$168.2K | -$182.2K | -$159.2K | $7M | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $181.2K | $114K | $13.1K | $7.4K | $5.8K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $6.5K | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $7.5K | $8.2K | $8.6K | $9.2K | $8.5K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $544.2K | $346.6K | $444.7K | $16.6K | $14.3K | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $1.8M | $1.8M | $1.8M | $2.5M | $8.6M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.4M | $2.2M | $2.3M | $2.5M | $8.6M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $42.7K | $13.3K | $304.6K | $695.2K | $937.2K | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $42.7K | $13.3K | $304.6K | $695.2K | $937.2K | |
Common Stock | $17.6M | $17.6M | $17.6M | $17.6M | $17.6M | |
Other Common Equity Adj | -- | -- | -- | -- | $6.1M | |
Common Equity | $2.3M | $2.2M | $2M | $1.8M | $7.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.3M | $2.2M | $2M | $1.8M | $7.6M | |
Total Liabilities and Equity | $2.4M | $2.2M | $2.3M | $2.5M | $8.6M | |
Cash and Short Terms | $181.2K | $114K | $13.1K | $7.4K | $5.8K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $181.2K | $114K | $13.1K | $7.4K | $5.8K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $6.5K | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $7.5K | $8.2K | $8.6K | $9.2K | $8.5K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $544.2K | $346.6K | $444.7K | $16.6K | $14.3K | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $1.8M | $1.8M | $1.8M | $2.5M | $8.6M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2.4M | $2.2M | $2.3M | $2.5M | $8.6M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $42.7K | $13.3K | $304.6K | $695.2K | $937.2K | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $42.7K | $13.3K | $304.6K | $695.2K | $937.2K | |
Common Stock | $17.6M | $17.6M | $17.6M | $17.6M | $17.6M | |
Other Common Equity Adj | -- | -- | -- | -- | $6.1M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.3M | $2.2M | $2M | $1.8M | $7.6M | |
Total Liabilities and Equity | $2.4M | $2.2M | $2.3M | $2.5M | $8.6M | |
Cash and Short Terms | $181.2K | $114K | $13.1K | $7.4K | $5.8K | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$187.1K | -$168.2K | -$193.2K | -$191.8K | -$244.4K | |
Depreciation & Amoritzation | $210 | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$3.5K | $6.5K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$271.7K | -$191.8K | -$180.9K | -$158.2K | -$156.9K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$347.1K | $124.6K | -$198.6K | -$204K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $278.6K | $356.5K | $155.3K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$89.3K | -- | -- | -- | -- | |
Cash From Financing | $757.5K | -- | $278.6K | $356.5K | $155.3K | |
Beginning Cash (CF) | $42.6K | $181.2K | $114K | $13.1K | $7.4K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $138.7K | -$67.2K | -$100.9K | -$5.7K | -$1.7K | |
Ending Cash (CF) | $181.2K | $114K | $13.1K | $7.4K | $5.8K | |
Levered Free Cash Flow | -$271.7K | -$191.8K | -$180.9K | -$158.2K | -$156.9K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$44.9K | -$46.6K | -$50.2K | -$58.8K | -$85.8K | |
Depreciation & Amoritzation | $90 | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $5.8K | $3.9K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$61.1K | -$51.3K | -$36.8K | -$44.5K | -$78.7K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$940 | $124.6K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $20K | $246.5K | $52K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.5K | -- | -- | -- | -- | |
Cash From Financing | -$2.5K | -- | $20K | $246.5K | $52K | |
Beginning Cash (CF) | $245.8K | $40.8K | $29.9K | $9.5K | $32.5K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$64.5K | $73.3K | -$16.8K | -$2K | -$26.7K | |
Ending Cash (CF) | $181.2K | $114K | $13.1K | $7.4K | $5.8K | |
Levered Free Cash Flow | -$61.1K | -$51.3K | -$36.8K | -$44.5K | -$78.7K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$187.1K | -$168.2K | -$193.2K | -$191.8K | -$244.4K | |
Depreciation & Amoritzation | $200 | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$3.4K | $6.5K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$271.7K | -$191.8K | -$180.9K | -$158.2K | -$156.9K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | $124.6K | -$198.6K | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $278.6K | $356.5K | $155.3K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$89.3K | -- | -- | -- | -- | |
Cash From Financing | $757.5K | -- | $278.6K | $356.5K | $155.3K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $138.7K | -$67.2K | -$100.9K | -$5.7K | -$1.7K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$271.7K | -$191.8K | -$180.9K | -$158.2K | -$156.9K |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$168.2K | -$193.2K | -$191.8K | -$244.4K | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $6.5K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$191.8K | -$180.9K | -$158.2K | -$156.9K | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $124.6K | -$198.6K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $278.6K | $356.5K | $155.3K | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | $278.6K | $356.5K | $155.3K | -- | |
Beginning Cash (CF) | $431.9K | $273.7K | $46.6K | $93.3K | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$67.2K | -$100.9K | -$5.7K | -$1.7K | -- | |
Ending Cash (CF) | $364.7K | $172.8K | $40.9K | $91.7K | -- | |
Levered Free Cash Flow | -$191.8K | -$181K | -$158.2K | -$156.9K | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.